超声增强剂在超声心动图中的临床应用现状及进展

许迪; 钱丽君

doi:10.13201/j.issn.1001-1439.2018.12.002

超声增强剂在超声心动图中的临床应用现状及进展

许迪^,,
钱丽君

- 南京医学科大学第一附属医院老年心血管科(南京, 210029)

详细信息

通讯作者: 许迪,E-mail:xudi@jsph.org.cn

中图分类号: R542.5

收稿日期: 2018-11-23

Clinical and emerging applications and research progress of ultrasonic enhancing agents in echocardiography

XU Di^,,
QIAN Lijun

- Department of Geriatrics Cardiovascular, The first affiliated hospital of Nanjing medical university, Nanjing 210029, China

More Information

Corresponding author: XU Di, E-mail: xudi@jsph.org.cn

Received Date: 23 November 2018

摘要

摘要: 2018年3月美国超声心动图学会发布了超声增强剂 (UEA) 在超声心动图中的临床应用指南, 对其应用范围进行了更新。UEA已广泛应用于左心室结构与功能评估、心内异常、负荷超声心动图、血管成像、重症及急诊监测以及部分儿科心脏成像等。其新型应用也在不断扩展中, 包括超声溶栓、分子成像、靶向药物及基因传递等。UEA有益于心血管疾病的早期诊治与治疗, 临床成本效益显著。
- 超声心动图 /
- 超声造影增强技术 /
- 超声增强剂
Abstract: The 2018 American Society of Echocardiography (ASE) guidelines have updated on clinical applications of ultrasonic enhancing agents in echocardiography.UEA has been widely used in the assessment of left ventricular functions, intracardiac abnormalities, stress echocardiography, vascular imaging, critical and emergency care setting, and pediatric echocardiography.Its emerging applications covers sonothrombolysis, molecular imaging, targeted drugs and gene delivery (UTMD) and flow augmentation with diagnostic UTMD.UEA benefits the early diagnostic and clinical outcomes in cardiovascular diseases, and the cost-effectiveness is in a wide variety of clinical settings.
- echocardiography /
- contrast echocardiography /
- ultrasound enhancing agent

HTML全文

参考文献(26)

[1]	Gramiak R, Shah PM.Echocardiography of the aortic root[J].Invest Radiol, 1968, 3:356-366.
[2]	Porter TR, Mulvagh SL, Abdelmoneim SS, et al.Clinical applications of ultrasonic enhancing agents in echocardiography:2018 American Society of Echocardiography Guidelines Update[J].J Am Soc Echocardiogr, 2018, 31 (3):241-274.
[3]	Appis AW, Tracy MJ, Feinstein SB.Update on the safety and efficacy of commercial ultrasound contrast agents in cardiac applications[J].Echo Res Pract, 2015, 2 (2):R55-62.
[4]	Paakkanen R, He W, Savu A, et al.Proposal for contrast-enhanced 2 Dechocardiography reference values in females[abstract].J Am Soc Echocardiogr, 2016, B68.
[5]	Hoffmann R, von Bardeleben S, Kasprzak JD, et al.A-nalysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography:a multicenter comparison of methods[J].J Am Coll Cardiol, 2006, 47 (1):121-128.
[6]	Weinsaft JW, Kim J, Medicheria CB, et al.Echocardiographic algorithm for post myocardial infarction LVthrombus:agatekeeper for thrombus evaluation by delayed enhancement CMR[J].JACC Cardiovasc Imaging, 2016, 9 (5):505-515.
[7]	Rowin EJ, Maron BJ, Hans TTS, et al.Hypertrophic cardiomyopathy with left ventricular apical aneurysm:Implicationsfor risk stratification and management[J].J Am Coll Cardiol, 2017, 69 (7):761-773.
[8]	Yamaguchi H, Ishimura T, Nishiyama S, et al.Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy):ventriculographic and echocardiographic features in 30patients[J].Am J Cardiol, 1979, 44 (3):401-412.
[9]	Jung PH, Mueller M, Schuhmann C, et al.Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce thromboembolic events[J].Cardiovasc Ultrasound, 2013, 11 (1):1.
[10]	Shah BN, Balaji G, Alhajiri A, et al.Incremental diagnostic and prognostic value of contemporary stress echocardiography in a chest pain unit:mortality and morbidity outcomes from a real-world setting[J].Circ Cardiovasc Imaging, 2013, 6 (2):202-209.
[11]	Leong-Poi H, Rim SJ, Le DE, et al.Perfusion versus function:the ischemic cascade in demand ischemia:implications of single-vessel versus multivessel stenosis[J].Circulation, 2002, 105 (8):987-992.
[12]	Abdelmoneim SS, Mulvagh SL, Xie F, et al.Regadenoson stress real time myocardial perfusion echocardiography for detection of coronary artery disease:feasibility and accuracy of two different ultrasound contrast agents[J].J Am Soc Echocardiograph, 2015, 28 (12):1393-1400.
[13]	Bredahl KK, Taudorf M, Lonn L, et al.Contrast enhanced ultrasound can replace computed tomography angiography for surveillance after endovascular aortic aneurysm repair[J].Eur J Vasc Endovasc Surg, 2016, 52 (6):729-734.
[14]	Main ML, Ryan AC, Davis TE, et al.Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4, 300, 966consecutive patients)[J].Am J Cardiol, 2008, 102 (12):1742-1746.
[15]	Wei K, Peters D, Belcik T, et al.Predictive instrument using contrast echocardiography in patients presenting to the emergency department with chest pain and without ST segment elevation[J].J Am Soc Echocardiogr, 2010, 23 (6):636-642.
[16]	Wyrick JJ, Kalvaitis S, McConnell J, et al.Costefficiency of myocardial contrast echocardiography in patients presenting to the emergency department with chest pain of suspected cardiac origin and a nondiagnostic electrocardiogram[J].Am J Cardiol, 2008, 102 (6):649-652.
[17]	Kutty S, Bisselou Moukagna KS, Craft M, et al.Clinical outcome of patients with inducible capillary blood flow abnormalities during demand stress in the presence or absence of angiographic coronary disease[J].Circ Cardiovasc imaging, 2018, 11 (10):e007483.
[18]	Lindner JR.Microvascular dysfunction and clinical outcomes[J].Circ Cardiovasc imaging, 2018, 11 (10):e008381.
[19]	Kutty S, Xiao Y, Olson J, et al.Safety and efficacy of cardiac ultrasound contrast in children and adolescents for resting and stress echocardiography[J].J Am Soc Echocardiogr, 2016, 29 (7):655-662.
[20]	Porter TR, Abdelmoneim S, Belchik JT, et al.Guidelines for the cardiac sonographer in the performance of contrast echocardiography:a focused update from the American Society of Echocardiography[J].J Am Soc Echocardiogr, 2014, 27 (8):797-810.
[21]	Xie F, Lof J, Everbach C, et al.Treatment of acute intravascular thrombi with diagnostic ultrasound and intravenous microbubbles[J].JACC Cardiovasc Imaging, 2009, 2 (2):511-581.
[22]	Chen X, Leeman JE, Wang J, et al.New insights into mechanisms of sonothrombolysis using ultra-highspeed imaging[J].Ultrasound Med Biol, 2014, 40 (1):258-262.
[23]	Xie F, Slikkerverr J, Gao S, et al.Coronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubbles in acute ST segment elevation myocardial infarction[J].J Am Soc Echocardiogr, 2011, 24 (12):1400-1408.
[24]	Belcik JT, Mott BH, Xie A, et al.Augmentation of limb perfusion and reversal of tissue ischemia produced by ultrasound-mediated microbubble cavitation[J].Circ Cardiovasc Imaging, 2015, 8 (4):e002979.
[25]	Nahrendorf M, Sosnovik DE, French BA, et al.Multimodality cardiovascular molecular imaging, part II[J].Circ Cardiovasc Imaging, 2009, 2 (1):56-70.
[26]	Wang J, Qin B, Chen X, et al.Ultrasound molecular imaging of angiogenesis using vascular endothelial growth factor conjugated microbubbles[J].Mol Pharm, 2017, 14 (3):781-790.